Schroder Investment Management Group grew its holdings in Humana Inc (NYSE:HUM) by 86.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 81,701 shares of the insurance provider’s stock after acquiring an additional 37,964 shares during the period. Schroder Investment Management Group owned about 0.06% of Humana worth $24,264,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Sun Life Financial INC lifted its stake in shares of Humana by 120.7% in the 2nd quarter. Sun Life Financial INC now owns 373 shares of the insurance provider’s stock valued at $111,000 after purchasing an additional 204 shares during the period. Financial Gravity Wealth Inc. acquired a new position in shares of Humana in the 1st quarter valued at $113,000. Migdal Insurance & Financial Holdings Ltd. lifted its stake in shares of Humana by 2,984.6% in the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 401 shares of the insurance provider’s stock valued at $119,000 after purchasing an additional 388 shares during the period. Summit Trail Advisors LLC lifted its stake in shares of Humana by 24,611.8% in the 1st quarter. Summit Trail Advisors LLC now owns 184,103 shares of the insurance provider’s stock valued at $184,000 after purchasing an additional 183,358 shares during the period. Finally, NuWave Investment Management LLC acquired a new position in shares of Humana in the 2nd quarter valued at $198,000. 92.99% of the stock is currently owned by institutional investors and hedge funds.
Several equities analysts recently issued reports on the stock. Cowen assumed coverage on shares of Humana in a research note on Monday, September 17th. They issued a “market perform” rating and a $372.00 target price for the company. SunTrust Banks boosted their target price on shares of Humana to $380.00 and gave the company a “hold” rating in a research note on Wednesday, September 19th. Argus boosted their target price on shares of Humana to $375.00 and gave the company a “buy” rating in a research note on Tuesday, September 4th. Credit Suisse Group boosted their target price on shares of Humana from $350.00 to $370.00 and gave the company an “outperform” rating in a research note on Tuesday, September 4th. Finally, Zacks Investment Research cut shares of Humana from a “buy” rating to a “hold” rating in a research note on Friday, October 5th. Seven research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Humana presently has an average rating of “Buy” and a consensus price target of $339.79.
NYSE:HUM opened at $318.35 on Friday. The company has a quick ratio of 1.43, a current ratio of 1.43 and a debt-to-equity ratio of 0.47. The firm has a market cap of $46.64 billion, a price-to-earnings ratio of 27.19, a P/E/G ratio of 1.69 and a beta of 0.97. Humana Inc has a fifty-two week low of $231.90 and a fifty-two week high of $341.30.
Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, August 1st. The insurance provider reported $3.96 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.79 by $0.17. The company had revenue of $14.26 billion during the quarter, compared to analysts’ expectations of $14.16 billion. Humana had a net margin of 2.48% and a return on equity of 17.43%. During the same period in the prior year, the business posted $3.49 earnings per share. As a group, equities research analysts predict that Humana Inc will post 14.18 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 26th. Shareholders of record on Friday, September 28th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.63%. The ex-dividend date of this dividend is Thursday, September 27th. Humana’s dividend payout ratio is presently 17.08%.
In other Humana news, SVP Cynthia H. Zipperle sold 4,886 shares of the company’s stock in a transaction on Friday, August 3rd. The shares were sold at an average price of $321.89, for a total transaction of $1,572,754.54. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Elizabeth D. Bierbower sold 3,092 shares of the company’s stock in a transaction on Thursday, August 16th. The stock was sold at an average price of $330.00, for a total transaction of $1,020,360.00. Following the transaction, the insider now owns 14,289 shares of the company’s stock, valued at $4,715,370. The disclosure for this sale can be found here. Insiders have sold 40,284 shares of company stock valued at $13,147,715 over the last 90 days. 0.60% of the stock is currently owned by company insiders.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.
Featured Article: Terms to Better Understand Call Options
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.